Levosimendan for sepsis-induced myocardial dysfunction: friend or foe?
Sepsis-induced myocardial dysfunction (SIMD) involves reversible myocardial dysfunction. The use of inotropes can restore adequate cardiac output and tissue perfusion, but conventional inotropes, such as dobutamine and adrenaline, have limited efficacy in such situations. Levosimendan is a novel ino...
Saved in:
Main Authors: | Xinxin Du, Fang Xiong, Yafei Hou, Xiangyou Yu, Pengfei Pan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2025-01-01
|
Series: | Frontiers in Cardiovascular Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fcvm.2024.1520596/full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pathological roles of ubiquitination and deubiquitination systems in sepsis-induced myocardial dysfunction
by: Zhiping Wang, et al.
Published: (2025-01-01) -
Exosomes Derived from Apelin-Pretreated Mesenchymal Stem Cells Ameliorate Sepsis-Induced Myocardial Dysfunction by Alleviating Cardiomyocyte Pyroptosis via Delivery of miR-34a-5p
by: Li T, et al.
Published: (2025-01-01) -
Clinical efficacy and hemodynamic effects of levosimendan in cardiac surgery patients after surgery
by: Meiling Zhao, et al.
Published: (2025-01-01) -
The Mechanisms of Sepsis Induced Coagulation Dysfunction and Its Treatment
by: Zhu L, et al.
Published: (2025-02-01) -
A CD36-based prediction model for sepsis-induced myocardial injury
by: Yun Xie, et al.
Published: (2025-04-01)